相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
Georgios Gemenetzis et al.
ANNALS OF SURGERY (2019)
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial
Jin-Young Jang et al.
ANNALS OF SURGERY (2018)
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
Shuji Isaji et al.
PANCREATOLOGY (2018)
Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies Where Are We?
Robert A. Wolff
SURGICAL CLINICS OF NORTH AMERICA (2018)
Pancreatic Adenocarcinoma, Version 2.2017
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification
J. W. Gilbert et al.
ANNALS OF ONCOLOGY (2017)
A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement
Yuichi Nagakawa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma
F. Giovinazzo et al.
BRITISH JOURNAL OF SURGERY (2016)
Neoadjuvant Therapy for Pancreatic Cancer Systematic Review of Postoperative Morbidity, Mortality, and Complications
Vivek Verma et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
R. Vera et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Justifying vein resection with pancreatoduodenectomy
Savio G. Barreto et al.
LANCET ONCOLOGY (2016)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker et al.
LANCET ONCOLOGY (2016)
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
M. Ducreux et al.
ANNALS OF ONCOLOGY (2015)
Approach to Patients With Pancreatic Cancer Without Detectable Metastases
Gregory M. Heestand et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement
Jin Ho Lee et al.
MEDICINE (2015)
A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma
Eileen M. O'Reilly et al.
ANNALS OF SURGERY (2014)
Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
J. Bart Rose et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
V. Heinemann et al.
ANNALS OF ONCOLOGY (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
Edward J. Kim et al.
CANCER (2013)
The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer
Thierry Conroy et al.
CURRENT ONCOLOGY REPORTS (2013)
Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies
Angelo Andriulli et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
A Systematic Review and Meta-analysis of Survival and Surgical Outcomes Following Neoadjuvant Chemoradiotherapy for Pancreatic Cancer
Jerome Martin Laurence et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
Jing Hu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005)
Michele M. Corsini et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prospective phase II trial of Neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head
Stefan Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins hospital
Joseph M. Herman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Borderline resectable pancreatic cancer: The importance of this emerging stage of disease
Matthew H. G. Katz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Gemcitabine-based combinations for inoperable pancreatic cancer:: Have we made real progress?: A meta-analysis of 20 phase 3 trials
Emilio Bria et al.
CANCER (2007)
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate
CMR Lima et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
A comparison of methods to detect publication bias in meta-analysis
P Macaskill et al.
STATISTICS IN MEDICINE (2001)